Immunosignature system for diagnosis of cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 30, 2014, Pages

  Stafford, Phillip ^a   Cichacz, Zbigniew ^a   Woodbury, Neal W ^a   Johnston, Stephen Albert ^a  

^a Arizona State University   (United States)

Author keywords

Antibody biomarker; Cancer diagnostic; Immunodiagnostic; Peptide microarray

Indexed keywords

ANTIBODY BIOMARKER; CANCER DIAGNOSTIC; IMMUNODIAGNOSTIC; PEPTIDE MICROARRAY;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; FEMALE; HUMANS; IMMUNOLOGIC TESTS; MALE; NEOPLASMS; PROTEIN ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84905040017     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1409432111     Document Type: Article

References (37)

1. De Cecco L, et al. (2009) Impact of biospecimens handling on biomarker research in breast cancer. BMC Cancer 9(1):409.
2. Mischak H, et al. (2010) Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med 2(46):46ps42.
3. Poste G (2011) Bring on the biomarkers. Nature 469(7329):156-157.
4. Ioannidis JPA (2013) Biomarker failures. Clin Chem 59(1):202-204.
5. Cramer DW, et al. (2011) Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) 4(3):365-374.
6. Reiman JM, Kmieciak M, Manjili MH, Knutson KL (2007) Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol 17(4):275-287. (Pubitemid 47211962)
7. Kotera Y, Fontenot JD, Pecher G, Metzgar RS, Finn OJ (1994) Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res 54(11):2856-2860. (Pubitemid 24187762)
8. Jäger E, et al. (1998) Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 187(2):265-270. (Pubitemid 28060443)
9. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21(2):137-148. (Pubitemid 39094044)
10. Hudson ME, Pozdnyakova I, Haines K, Mor G, Snyder M (2007) Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc Natl Acad Sci USA 104(44):17494-17499. (Pubitemid 350219866)
11. Darnell RB, Posner JB (2003) Paraneoplastic syndromes involving the nervous system. N Engl J Med 349(16):1543-1554. (Pubitemid 37255041)
12. Cooperman J, Neely R, Teachey DT, Grupp S, Choi JK (2004) Cell division rates of primary human precursor B cells in culture reflect in vivo rates. Stem Cells 22(6):1111-1120. (Pubitemid 39507096)
13. Sykes KF, Legutki JB, Stafford P (2013) Immunosignaturing: A critical review. Trends Biotechnol 31(1):45-51.
14. Halperin R, Stafford P, Legutki JB, Johnston SA (2010) Exploring antibody recognition of sequence space through random-sequence peptide microarrays. Mol Cell Proteomics 28(1):e101230-e101236.
15. Stafford P, et al. (2012) Physical characterization of the "immunosignaturing effect". Mol Cell Proteomics 11(4):011593.
16. Kukreja M, Johnston SA, Stafford P (2012) Immunosignaturing microarrays distinguish antibody profiles of related pancreatic diseases. Proteomics and Bioinformatics, 10.4172/jpb.S6-001.
17. Chase BA, Johnston SA, Legutki JB (2012) Evaluation of biological sample preparation for immunosignature-based diagnostics. Clin Vaccine Immunol 19(3):352-358.
18. Pauling L, Campbell DH (1942) The manufacture of antibodies in vitro. J Exp Med 76(2):211-220.
19. Hughes AK, et al. (2012) Immunosignaturing can detect products from molecular markers in brain cancer. PLoS ONE 7(7):e40201.
20. Sing T, Sander O, Beerenwinkel N, Lengauer T (2005) ROCR: Visualizing classifier performance in R. Bioinformatics 21(20):3940-3941. (Pubitemid 41535515)
21. Robin X, et al. (2011) pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12(1):77.
22. Fawcett T (2006) An introduction to ROC analysis. Pattern Recognit Lett 27(8):861-874.
23. Chen C, et al. (2011) Removing batch effects in analysis of expression microarray data: An evaluation of six batch adjustment methods. PLoS ONE 6(2):e17238.
24. Johnson WE, Li C, Rabinovic A (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8(1):118-127. (Pubitemid 44906106)
25. Brand RE, et al. (2011) Serum biomarker panels for the detection of pancreatic cancer. Clin Cancer Res 17(4):805-816.
26. Bracci PM, Zhou M, Young S, Wiemels J (2012) Serum autoantibodies to pancreatic cancer antigens as biomarkers of pancreatic cancer in a San Francisco Bay Area case-control study. Cancer 118(21):5384-5394.
27. Alberts B, et al. (2002) Molecular Biology of the Cell (Garland Science, New York), 4th Ed.
28. Butts CA (2013) Anti-tumor immune response in early stage non small cell lung cancer (NSCLC): Implications for adjuvant therapy. Transl Lung Cancer Res 2(5):415-422.
29. Savitskaya YA, et al. (2010) Circulating Natural IgM Antibodies Against Angiogenin in the Peripheral Blood Sera of Patients with Osteosarcoma as Candidate Biomarkers and Reporters of Tumorigenesis. Biomark Cancer 2:65-78.
30. Notkins AL (2004) Polyreactivity of antibody molecules. Trends Immunol 25(4):174-179.
31. Restrepo L, Stafford P, Magee DM, Johnston SA (2011) Application of immunosignatures to the assessment of Alzheimer's disease. Ann Neurol 70(2):286-295.
32. Restrepo L, Stafford P, Johnston SA (2013) Feasibility of an early Alzheimer's disease immunosignature diagnostic test. J Neuroimmunol 254(1-2):154-160.
33. Gius D, et al. (2007) Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates. Cancer Res 67(15):7113-7123. (Pubitemid 47206538)
34. Vargas AC, et al. (2012) Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression. Breast Cancer Res Treat 135(1):153-165.
35. Halperin RF, Stafford P, Emery JS, Navalkar KA, Johnston SA (2012) GuiTope: An application for mapping random-sequence peptides to protein sequences. BMC Bioinformatics 13(1):1.
36. Hartwell L, Mankoff D, Paulovich A, Ramsey S, Swisher E (2006) Cancer biomarkers: A systems approach. Nat Biotechnol 24(8):905-908. (Pubitemid 44215377)
37. Förster I, Rajewsky K (1990) The bulk of the peripheral B-cell pool in mice is stable and not rapidly renewed from the bone marrow. Proc Natl Acad Sci USA 87(12):4781-4784.